Idenix Pharmaceuticals to Present at the 2010 Wells Fargo Securities Healthcare Conference

CAMBRIDGE, Mass., June 16 /PRNewswire-FirstCall/ -- Idenix Pharmaceuticals, Inc. (Nasdaq: IDIX) announced today that Idenix management will present a corporate overview at the 2010 Wells Fargo Securities Healthcare Conference on Wednesday, June 23, 2010 at 8:00 a.m. ET at the InterContinental hotel, Boston.

The live and archived webcast of the company presentation can be accessed under "Calendar of Events" in the Idenix Investor Center at  Please log in approximately 5-10 minutes before the event to ensure a timely connection.  The archived replay will be available on the Idenix website for two weeks following the conference.  

About Idenix

Idenix Pharmaceuticals, Inc., headquartered in Cambridge, Massachusetts, is a biopharmaceutical company engaged in the discovery and development of drugs for the treatment of human viral diseases. Idenix's current focus is on the treatment of patients with chronic hepatitis C infection. For further information about Idenix, please refer to

Idenix Pharmaceuticals Contacts:

Teri Dahlman: 617-995-9905 (media)

Jonae Barnes: 617-224-4485 (investors)

SOURCE Idenix Pharmaceuticals, Inc.